Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Debt Ratio (2019 - 2020)

Ovid Therapeutics filings provide 2 years of Debt Ratio readings, the most recent being 0.03 for Q4 2020.

  • Quarterly Debt Ratio rose 770.89% to 0.03 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 0.03 through Dec 2020, up 770.89% year-over-year, with the annual reading at 0.03 for FY2020, 770.89% up from the prior year.
  • Debt Ratio hit 0.03 in Q4 2020 for Ovid Therapeutics, up from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.03 in Q4 2020 and bottomed at 0.0 in Q3 2020.